Top compounds associated with response to STXBP2


Feature Type Standardized
Nominal ANOVA
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.19 1e-07
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.31 6e-07
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA Erlotinib CCLE pan-cancer AAC 0.26 4e-06
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.17 7e-06
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 8e-06
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.19 8e-06
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA KIN001-055 GDSC1000 pan-cancer AAC 0.16 1e-05
Download CSV